Chapter 3: Blood pressure management in CKD ND patients without diabetes mellitus.

Kidney Int Suppl (2011) · 2012 · PMC4089593 · PMID 25018962

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Fosinopril decreased albumin excretion by 26% and showed a trend toward reducing the risk of CVD outcomes (hazard ratio [HR] versus placebo 0.60; 95% CI 0.33–1.10). 190 Similarly, in the CASE J trial, candesartan reduced the rate of CVD outcomes, as compared with amlodipine, in CKD 4 patients 178 (Supplementary Table 5 online).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.